The Effects of Sugammadex On Coagulation In Pregnant Rats

Some studies have reported that sugammadex affects coagulation parameters. However, the effects of sugammadex on coagulation in pregnant women have not been adequately evaluated. This study investigated the effects of sugammadex administration on routine coagulation tests and levels of coagulation factors (FII, FV, FVII, FVIII, FIX, and FX) in pregnant rats. After ethics committee approval (2019/06), 24 female Wistar albino rats (n = 12; 19–20 days of gestation; weight 230–380 g) were randomly divided into four groups: control (n = 6), sugammadex (n = 6), pregnant (n = 6), and pregnant sugammadex (n = 6). Ketamine (50 mg/kg) and xylazine (10 mg/kg) were administered intraperitoneally to all groups. Saline (SF) (1 ml/kg) was administered to the control and pregnant groups. Sugammadex was administered to the sugammadex and pregnant sugammadex groups at a dose of 16 mg/kg. Blood samples were collected at 30 min after SF and sugammadex administration in all rats. The levels of PT, INR, aPTT, fibrinogen and coagulation factors were measured in plasma obtained from blood samples. All animals were sacrificed by cervical dislocation after the procedure. The mean weights of the rats were significantly higher in the pregnant groups (pregnant and pregnant sugammadex groups) than in the non-pregnant groups (control and sugammadex groups). The mean PT and INR values were significantly lower in the pregnant than non-pregnant groups. No significant differences were observed in any of the parameters evaluated between the sugammadex- and SF-administered groups. Sugammadex administration did not affect routine coagulation tests or the levels of coagulation factors in pregnant rats.

___

1.Naguib M, Lien C.A. Pharmacology of muscle relaxant and theirantagonists. In: Miller RD (ed.) Miller’s Anesthesia. 7th edition. Philadelphia: Churchill Livingstone Elsevier 2010;859-911.

2.Belgin A. The Inhibitors of Cholinesterase (Anticholinesterases). Turkiye Klinikleri J Int Med Sci2005;1:47-57.

3.EMA: helping doctors help patients [Internet]. Amsterdam: European Medicines Agency; ©1995-2019 [cited 2019 June 17]. Available from: https://www.ema.europa.eu/en/documents/product-information/bridion-epar-product-information_en.pdf

4.Dirkmann D, Britten MW, Pauling H, Weidle J, Volbracht L, Görlinger K, et al. Anticoagulant Effect of Sugammadex: Just an In Vitro Artifact. Anesthesiology 2016; 124:1277-1285.

5.Rahe-Meyer N, Fennema H, Schulman S, Klimscha W, Przemeck M, Blobner M et al. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. Anesthesiology 2014; 121:969-977.

6.D’Angelo R. Anaesthesia-related maternal mortality: a pat on the back or call to arms. Anesthesiology 2007; 106:1082-1084.

7.Hawkins JL, Chang J, Palmer SK, Gibbs CP, Callaghan WM. Anaesthesia-related maternal mortality in the United States: 1979-2002. Obstetric Gynaecol 2011; 117: 69-74.

8.Hellgren M. Hemostasis in normal pregnancy and puerperium. Semin Thromb Hemost 2003;26: 244-247.

9.Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemostas 1984; 52: 176-182.

10.Sucak G,Sucak A. Pregnancy and Hypercoagulability. Turkiye Klinikleri J Int Med Sci 2001; 1: 40-47.

11.Raft J, Guerci P, Harter V, Fuchs-Buder T, Meistelman C. Biological evaluation of the effect of sugammadex on hemostasis and bleeding. Korean journal of anesthesiology2015; 68: 17-21.

12.De Kam PJ, Grobara P, Prohn M, Höppener F, Kluft C, Burggraaf J et al. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects. International journal of clinical pharmacology and therapeutics 2014; 52: 227-236.

13.Taş N, Korkmaz H., Yağan Ö, Korkmaz M. Effect of sugammadex on postoperative bleeding and coagulation parameters after septoplasty: a randomized prospective study. Medical science monitor: international medical journal of experimental and clinical research2015; 21: 2382-2386.
Eastern Journal of Medicine-Cover
  • ISSN: 1301-0883
  • Başlangıç: 1996
  • Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler

The role of Human Cytomegalovirus (HCMV) in Patients with Active Coeliac Disease (CD)

Inas K. SHARQUIE, Shatha F. ABDULLAH, Aytan M. AL BAYATI

Evaluation of The Histopathological Analysis and Surgical Indication of The Gallbladder Polyps Determined By Ultrasonography

Nazmi ÖNER, Feyzi KURT

Evaluation of Serum Levels of Trace Elements in Myeloproliferative Neoplasms: A Case-Control Study

Fatih YETİŞGİN, Ramazan ESEN, Mustafa BİLİCİ

Diagnostic Value of Neutrophil To Lymphocyte Ratio For Assessing The Disease Severity In Covid-19 Patients

Ngakan Ketut Wira SUASTIKA, Ketut SUEGA

Shaping Efficiency of WaveOne Gold and One Curve in Simulated J-Shaped Root Canals

Ayfer ATAV ATEŞ, Burçin ARICAN

The Effects of Sugammadex On Coagulation In Pregnant Rats

Mehmet Emin KESKİN, Havva SAYHAN KAPLAN, Nurcin GULHAS, Yasemin BAYRAM, YILDIRAY BAŞBUĞAN

Outcomes of Splenectomy for Hematologic Diseases - A Single Center Experience

Iskan ÇALLI, Fırat ASLAN, Ümit Haluk ILİKLERDEN, Remzi KIZILTAN, Mehmet Çetin KOTAN

Drug-Drug Interactions In The Risky Population: Elderly, Urological Patients Admitted To The Intensive Care Unit

Muhammet Serdar BUĞDAY, Ersoy ÖKSÜZ

Are Appendix Weight and Length Related to Inflammatory Parameters and Alvarado Score in Acute Appendicitis?

Remzi KIZILTAN, Iskan ÇALLI, Ali Rıza KARAYIL, Abbas ARAS, Mehmet Çetin KOTAN

Impact of YouTube platform in the Realm of Interventional Cardiology Techniques Such as: Double Kissing Crush

Flora OZKALAYCI, Emrah ERDOĞAN